Cancer radiotheranostics targeting carbonic anhydrase-IX with 111In- and 90Y-labeled ureidosulfonamide scaffold for SPECT imaging and radionuclide-based therapy
Conclusion: These results indicate that cancer radiotheranostics with [111In/90Y]US2 provides a novel strategy of theranostics for cancer hypoxia.
Source: Theranostics - Category: Molecular Biology Authors: Shimpei Iikuni, Masahiro Ono, Hiroyuki Watanabe, Yoichi Shimizu, Kohei Sano, Hideo Saji Tags: Research Paper Source Type: research
More News: Cancer | Cancer & Oncology | CT Scan | Hematology | SPECT | Students | Study | Toxicology | Universities & Medical Training